DOHaD: ONE WORLD ONE HEALTH
1. Abstract submission for DOHaD: One World One Health has been extended until September 7th, 2020.
2. Approved abstracts for poster and oral presentation will be announced from September 20th, 2020.
Abstract Preparation and Submission Guidance
DOHaD: One World One Health welcomes the submission of abstracts in fields related to the topics of the Meeting:
- DOHaD and nutrition
- DOHaD and exercise
- DOHaD and xenobiotic exposition
- DOHaD and abuse drugs
- DOHaD and stress
- DOHaD and aging
- DOHaD and pregnancy-related disorders
- DOHaD and infectious and parasitic diseases
- DOHaD and non-transmissible chronic diseases
Each abstract will be peer reviewed for the scientific merit of the research, and adherence to standard formatting rules outlined. The decision to accept or reject an abstract rests on the DOHaD: One World One Health Scientific Program Advisory Committee. Accepted abstracts will be selected for presentation at the DOHaD: One World One Health as poster or oral presentation and published online.
Abstracts may be submitted for (a) poster-only, or (b) oral and poster presentation. Each participant in the Meeting may submit a maximum of one abstract. Space for oral presentations is limited and therefore the Advisory Committee may need to override your preference. Both, poster and oral presentation will be in English. Oral presentation will integrate the main sessions and will be performed as a previously 10-min recorded video followed by a 10-min live discussion at the session’s end. Poster presentation will also be previously recorded, during no more than 3 minutes, and send to the organizers in advance, in order to be available to the attendees. The presenting author is expected to be online at the assigned time period to discuss the study and to answer questions virtually (more details will be provided before the meeting).
Approved abstracts will be published in the Biomedical and Biopharmaceutical Research Journal / Jornal de Investigação Biomédica e Biofarmacêutica. The journal’s link is and the publication will be made similar to this publication: ( ).
Abstract Formatting Instructions
The abstract must be written in English in a text editing format (e.g. Microsoft Word). Proposals for individual oral communications and posters should be submitted as a structured abstract in a single-spaced document using Times New Roman 12-point font. Title must be initial caps throughout, bold. Example: Early Life Stress and Altered Behavior in the Adult. The title is followed by the names and affiliations of the authors. First author must be the presenter. Abstracts must include the following sets of required fields: Background, Methods, Results, and Conclusions. Key-words, limited to four. Financial Support may be included in the last line.
References should be avoided, and used only if absolutely necessary (quote the first author, abbreviated journal and year).
Use standard abbreviations for units of measure. Other abbreviations should be spelled out in full at the first mention, followed by the abbreviation in parenthesis, except for classical abbreviations: DNA, PCR, ATP, H2O2, etc.
Do not include figures and tables.
The limit for abstract submission is 4,000 characters including spaces (including all abstract structure).